<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font4" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font5" size="10" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font6" size="7" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font7" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font8" size="9" family="SymbolMT" color="#000000"/>
	<fontspec id="font9" size="10" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font10" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
<text top="42" left="57" width="181" height="7" font="font0" id="p1_t1" reading_order_no="1" segment_no="0" tag_type="title">Breast Cancer Research Vol 7 No 1    Wang et al.<b>Breast Cancer Research</b></text>
<text top="735" left="18" width="19" height="8" font="font3" id="p1_t2" reading_order_no="0" segment_no="13" tag_type="text">R148</text>
<text top="82" left="57" width="240" height="12" font="font4" id="p1_t3" reading_order_no="2" segment_no="1" tag_type="text">µ l/ml; Sigma-Aldrich) was added at the same time to block<i>et al.</i></text>
<text top="97" left="57" width="241" height="9" font="font5" id="p1_t4" reading_order_no="3" segment_no="1" tag_type="text">cytokine secretion. The cells were washed after 5 hours and</text>
<text top="108" left="57" width="240" height="10" font="font5" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">resuspended at 10 7 cells/ml in staining buffer (Dulbecco's</text>
<text top="120" left="57" width="240" height="9" font="font5" id="p1_t6" reading_order_no="5" segment_no="1" tag_type="text">PBS without Mg 2+ or Ca 2+ , 1% heat-inactivated FCS, w/v</text>
<text top="132" left="57" width="240" height="9" font="font5" id="p1_t7" reading_order_no="6" segment_no="1" tag_type="text">0.09% sodium azide; pH adjusted to 7.4–7.6). The cells</text>
<text top="144" left="57" width="241" height="9" font="font5" id="p1_t8" reading_order_no="7" segment_no="1" tag_type="text">were then incubated for 15 min with purified 2.4 G2 anti-</text>
<text top="153" left="57" width="240" height="12" font="font5" id="p1_t9" reading_order_no="8" segment_no="1" tag_type="text">body 10 µ g/ml (PharMingen) to block nonspecific staining</text>
<text top="167" left="57" width="241" height="9" font="font5" id="p1_t10" reading_order_no="9" segment_no="1" tag_type="text">by fluorochrome-conjugated antibodies via Fc receptors.</text>
<text top="179" left="57" width="240" height="9" font="font5" id="p1_t11" reading_order_no="10" segment_no="1" tag_type="text">The cells were washed twice with staining buffer, and 10 6</text>
<text top="188" left="57" width="240" height="12" font="font5" id="p1_t12" reading_order_no="11" segment_no="1" tag_type="text">cells were stained with 1 µ g FITC-labeled anti-mouse CD8a</text>
<text top="200" left="57" width="240" height="12" font="font5" id="p1_t13" reading_order_no="12" segment_no="1" tag_type="text">and PerCP-labeled anti-mouse CD3e (PharMingen) in 50 µ l</text>
<text top="214" left="57" width="241" height="9" font="font5" id="p1_t14" reading_order_no="13" segment_no="1" tag_type="text">staining buffer at 4°C for 30 min. The cells were again</text>
<text top="226" left="57" width="241" height="9" font="font5" id="p1_t15" reading_order_no="14" segment_no="1" tag_type="text">washed twice with staining buffer, followed by fixation and</text>
<text top="238" left="57" width="241" height="9" font="font5" id="p1_t16" reading_order_no="15" segment_no="1" tag_type="text">permeabilization with Perm/Wash (Cytofix/Cytoperm Kits;</text>
<text top="250" left="57" width="241" height="9" font="font5" id="p1_t17" reading_order_no="16" segment_no="1" tag_type="text">PharMingen) for 20 min at 4°C. The cells were washed twice</text>
<text top="258" left="57" width="241" height="12" font="font5" id="p1_t18" reading_order_no="17" segment_no="1" tag_type="text">and resuspended in 50 µ l of the same solution. PE-conju-</text>
<text top="270" left="57" width="241" height="12" font="font5" id="p1_t19" reading_order_no="18" segment_no="1" tag_type="text">gated anti-interferon (IFN)- γ monoclonal antibody (0.5 µ g/</text>
<text top="284" left="57" width="241" height="10" font="font5" id="p1_t20" reading_order_no="19" segment_no="1" tag_type="text">10 6 cells; PharMingen) was added and the suspension was</text>
<text top="297" left="57" width="241" height="9" font="font5" id="p1_t21" reading_order_no="20" segment_no="1" tag_type="text">incubated for 30 min at 4°C. The cells were then washed</text>
<text top="308" left="57" width="240" height="9" font="font5" id="p1_t22" reading_order_no="21" segment_no="1" tag_type="text">twice with Perm/Wash solution and resuspended in staining</text>
<text top="320" left="56" width="26" height="9" font="font5" id="p1_t23" reading_order_no="22" segment_no="1" tag_type="text">buffer.</text>
<text top="344" left="57" width="241" height="9" font="font5" id="p1_t24" reading_order_no="23" segment_no="4" tag_type="text">The FACScan was used to analyze the percentage of intra-</text>
<text top="352" left="57" width="241" height="12" font="font5" id="p1_t25" reading_order_no="24" segment_no="4" tag_type="text">cellular IFN- γ -containing cells among the CD3 + and CD8 +</text>
<text top="367" left="57" width="241" height="9" font="font5" id="p1_t26" reading_order_no="25" segment_no="4" tag_type="text">cells. Isotype controls for anti-CD3a, anti-CD8e, and anti-</text>
<text top="376" left="57" width="241" height="12" font="font5" id="p1_t27" reading_order_no="26" segment_no="4" tag_type="text">IFN- γ (PharMingen) were subtracted from the acquired data.</text>
<text top="400" left="57" width="241" height="11" font="font7" id="p1_t28" reading_order_no="27" segment_no="5" tag_type="title">ELISPOT analysis of IFN- γ production by immune spleen</text>
<text top="414" left="57" width="20" height="8" font="font7" id="p1_t29" reading_order_no="28" segment_no="5" tag_type="title">cells</text>
<text top="426" left="57" width="241" height="9" font="font5" id="p1_t30" reading_order_no="29" segment_no="6" tag_type="text">The procedure for the ELISPOT technique was obtained</text>
<text top="438" left="57" width="240" height="9" font="font5" id="p1_t31" reading_order_no="30" segment_no="6" tag_type="text">from PharMingen, whose reagents were used whenever</text>
<text top="449" left="57" width="240" height="9" font="font5" id="p1_t32" reading_order_no="31" segment_no="6" tag_type="text">possible. The wells of an ELISPOT plate (CTL Immunospot</text>
<text top="461" left="57" width="241" height="9" font="font5" id="p1_t33" reading_order_no="32" segment_no="6" tag_type="text">plate; Cellular Technology Ltd, Cleveland, OH, USA) were</text>
<text top="470" left="57" width="240" height="12" font="font5" id="p1_t34" reading_order_no="33" segment_no="6" tag_type="text">coated overnight at 4°C with 100 µ l anti-mouse IFN- γ (2</text>
<text top="482" left="57" width="240" height="12" font="font4" id="p1_t35" reading_order_no="34" segment_no="6" tag_type="text">µ g/ml; PharMingen) diluted at 1:200 in coating buffer</text>
<text top="496" left="57" width="240" height="9" font="font5" id="p1_t36" reading_order_no="35" segment_no="6" tag_type="text">(PBS, pH 7.2). The coated wells were washed with block-</text>
<text top="508" left="57" width="240" height="9" font="font5" id="p1_t37" reading_order_no="36" segment_no="6" tag_type="text">ing solution (R10S medium), fresh blocking solution was</text>
<text top="520" left="57" width="241" height="9" font="font5" id="p1_t38" reading_order_no="37" segment_no="6" tag_type="text">added to each well, and then the plate was incubated for 2</text>
<text top="532" left="57" width="240" height="9" font="font5" id="p1_t39" reading_order_no="38" segment_no="6" tag_type="text">hours at room temperature. The blocking solution was then</text>
<text top="540" left="57" width="240" height="12" font="font5" id="p1_t40" reading_order_no="39" segment_no="6" tag_type="text">discarded and 100 µ l A2L2 cells (2 × 10 5 -1 × 10 6 ) was</text>
<text top="555" left="57" width="172" height="9" font="font5" id="p1_t41" reading_order_no="40" segment_no="6" tag_type="text">added to each well of the ELISPOT plate.</text>
<text top="579" left="57" width="241" height="9" font="font5" id="p1_t42" reading_order_no="41" segment_no="10" tag_type="text">Immune spleens were dissected from vaccinated mice and</text>
<text top="590" left="57" width="240" height="9" font="font5" id="p1_t43" reading_order_no="42" segment_no="10" tag_type="text">were prepared as already described for tetramer analysis.</text>
<text top="602" left="57" width="241" height="9" font="font5" id="p1_t44" reading_order_no="43" segment_no="10" tag_type="text">Increasing numbers of spleen cells (5 × 10 6 - 2 × 10 7 ) in 100</text>
<text top="611" left="57" width="240" height="12" font="font4" id="p1_t45" reading_order_no="44" segment_no="10" tag_type="text">µ l R10S medium were added to the wells, and the plate was</text>
<text top="626" left="57" width="240" height="10" font="font5" id="p1_t46" reading_order_no="45" segment_no="10" tag_type="text">incubated for 24 hours at 37°C in a 5% CO 2 atmosphere at</text>
<text top="637" left="57" width="241" height="9" font="font5" id="p1_t47" reading_order_no="46" segment_no="10" tag_type="text">99% humidity. Wells containing only spleen cells served as</text>
<text top="649" left="57" width="240" height="9" font="font5" id="p1_t48" reading_order_no="47" segment_no="10" tag_type="text">negative controls, and spleen cells from VRP- neu -vacci-</text>
<text top="658" left="57" width="240" height="12" font="font5" id="p1_t49" reading_order_no="48" segment_no="10" tag_type="text">nated mice cultured overnight with 5 µ g/ml concanavalin A</text>
<text top="673" left="57" width="241" height="9" font="font5" id="p1_t50" reading_order_no="49" segment_no="10" tag_type="text">(Sigma-Aldrich) served as a positive control. The cell sus-</text>
<text top="684" left="57" width="241" height="9" font="font5" id="p1_t51" reading_order_no="50" segment_no="10" tag_type="text">pension was aspirated, and the wells were washed twice</text>
<text top="696" left="57" width="241" height="9" font="font5" id="p1_t52" reading_order_no="51" segment_no="10" tag_type="text">with deionized water and were then soaked with deionized</text>
<text top="708" left="57" width="241" height="9" font="font5" id="p1_t53" reading_order_no="52" segment_no="10" tag_type="text">water for 5 min. The wells were washed three times with</text>
<text top="720" left="57" width="198" height="9" font="font5" id="p1_t54" reading_order_no="53" segment_no="10" tag_type="text">wash buffer I (PBS containing 0.05% Tween-20).</text>
<text top="82" left="315" width="241" height="12" font="font5" id="p1_t55" reading_order_no="54" segment_no="2" tag_type="text">The detection antibody, biotinylated anti-mouse IFN- γ</text>
<text top="94" left="315" width="241" height="12" font="font5" id="p1_t56" reading_order_no="55" segment_no="2" tag_type="text">(PharMingen), was diluted to 2 µ g/ml in dilution buffer (PBS</text>
<text top="106" left="315" width="241" height="12" font="font5" id="p1_t57" reading_order_no="56" segment_no="2" tag_type="text">containing 10% FBS), and 100 µ l was added to each well.</text>
<text top="120" left="315" width="241" height="9" font="font5" id="p1_t58" reading_order_no="57" segment_no="2" tag_type="text">The plate was incubated at room temperature for 2 hours,</text>
<text top="132" left="315" width="241" height="9" font="font5" id="p1_t59" reading_order_no="58" segment_no="2" tag_type="text">and the wells were washed three times with buffer I. Avidin–<b>ELISPOT analysis of IFN-</b></text>
<text top="144" left="315" width="241" height="9" font="font5" id="p1_t60" reading_order_no="59" segment_no="2" tag_type="text">horseradish peroxidase reagent (PharMingen) was diluted to</text>
<text top="153" left="315" width="241" height="12" font="font5" id="p1_t61" reading_order_no="60" segment_no="2" tag_type="text">1:100 in dilution buffer, and 100 µ l was added to each well,<b> production by immune spleen </b></text>
<text top="167" left="315" width="241" height="9" font="font5" id="p1_t62" reading_order_no="61" segment_no="2" tag_type="text">which was then incubated at room temperature for 1 hour.<b>cells</b></text>
<text top="179" left="315" width="241" height="9" font="font5" id="p1_t63" reading_order_no="62" segment_no="2" tag_type="text">The wells were washed four times with wash buffer I and</text>
<text top="191" left="315" width="241" height="9" font="font5" id="p1_t64" reading_order_no="63" segment_no="2" tag_type="text">twice with wash buffer II (PBS). A stock solution containing</text>
<text top="203" left="315" width="241" height="9" font="font5" id="p1_t65" reading_order_no="64" segment_no="2" tag_type="text">100 mg 3-amino-9-ethyl-carbazole (Sigma) dissolved in 10</text>
<text top="214" left="315" width="241" height="9" font="font5" id="p1_t66" reading_order_no="65" segment_no="2" tag_type="text">ml N , N -dimethylformamide (Sigma-Aldrich) was prepared.</text>
<text top="223" left="315" width="240" height="12" font="font5" id="p1_t67" reading_order_no="66" segment_no="2" tag_type="text">The final substrate solution was made by adding 333 µ l 3-</text>
<text top="238" left="315" width="241" height="9" font="font5" id="p1_t68" reading_order_no="67" segment_no="2" tag_type="text">amino-9-ethyl-carbazole stock solution to 10 ml of 0.1 M</text>
<text top="250" left="315" width="241" height="9" font="font5" id="p1_t69" reading_order_no="68" segment_no="2" tag_type="text">sodium acetate (pH 5.0), followed by filtering through a</text>
<text top="258" left="315" width="241" height="14" font="font5" id="p1_t70" reading_order_no="69" segment_no="2" tag_type="text">0.45- µ m filter. Five microliters of 30% H 2 O 2 was added to</text>
<text top="273" left="315" width="184" height="9" font="font5" id="p1_t71" reading_order_no="70" segment_no="2" tag_type="text">the substrate solution immediately before use.</text>
<text top="297" left="315" width="240" height="9" font="font5" id="p1_t72" reading_order_no="71" segment_no="3" tag_type="text">One hundred microliters of the final substrate solution was</text>
<text top="308" left="315" width="241" height="9" font="font5" id="p1_t73" reading_order_no="72" segment_no="3" tag_type="text">added to each well, and the plate was incubated in the dark</text>
<text top="320" left="315" width="240" height="9" font="font5" id="p1_t74" reading_order_no="73" segment_no="3" tag_type="text">for 5–60 min at room temperature. The reaction was</text>
<text top="332" left="315" width="240" height="9" font="font5" id="p1_t75" reading_order_no="74" segment_no="3" tag_type="text">stopped by washing the wells with deionized water. The</text>
<text top="344" left="315" width="241" height="9" font="font5" id="p1_t76" reading_order_no="75" segment_no="3" tag_type="text">plate was air-dried overnight at room temperature in the</text>
<text top="355" left="315" width="240" height="9" font="font5" id="p1_t77" reading_order_no="76" segment_no="3" tag_type="text">dark and sent to ZellNet Consulting, Inc. http://www.zell</text>
<text top="367" left="315" width="240" height="9" font="font5" id="p1_t78" reading_order_no="77" segment_no="3" tag_type="text">net.com, where the spots were enumerated automatically</text>
<text top="379" left="315" width="240" height="9" font="font5" id="p1_t79" reading_order_no="78" segment_no="3" tag_type="text">using an ImmunoSpot Series I analyzer (BD Biosciences).</text>
<text top="391" left="315" width="240" height="9" font="font5" id="p1_t80" reading_order_no="79" segment_no="3" tag_type="text">If overlapping spots (confluence) were present in the wells,</text>
<text top="402" left="315" width="240" height="9" font="font5" id="p1_t81" reading_order_no="80" segment_no="3" tag_type="text">the number of spots in a nonconfluent area of that well was</text>
<text top="414" left="315" width="241" height="9" font="font5" id="p1_t82" reading_order_no="81" segment_no="3" tag_type="text">determined. To estimate the total number of spots in each</text>
<text top="426" left="315" width="240" height="9" font="font5" id="p1_t83" reading_order_no="82" segment_no="3" tag_type="text">well with confluence, the following equation was used: total</text>
<text top="438" left="315" width="241" height="9" font="font5" id="p1_t84" reading_order_no="83" segment_no="3" tag_type="text">spot number = spot count + 2 × (spot count × % conflu-</text>
<text top="449" left="315" width="131" height="9" font="font5" id="p1_t85" reading_order_no="84" segment_no="3" tag_type="text">ence / [100% - % confluence]).</text>
<text top="473" left="315" width="81" height="8" font="font7" id="p1_t86" reading_order_no="85" segment_no="7" tag_type="title">Statistical analysis</text>
<text top="485" left="315" width="240" height="9" font="font5" id="p1_t87" reading_order_no="86" segment_no="8" tag_type="text">Student's t test was performed using Prism 4.0 Graphpad</text>
<text top="496" left="315" width="240" height="9" font="font5" id="p1_t88" reading_order_no="87" segment_no="8" tag_type="text">Software (San Diego, CA, USA). Statistical analysis, power</text>
<text top="508" left="315" width="240" height="9" font="font5" id="p1_t89" reading_order_no="88" segment_no="8" tag_type="text">analysis and the sample size per group were evaluated and</text>
<text top="520" left="315" width="240" height="9" font="font5" id="p1_t90" reading_order_no="89" segment_no="8" tag_type="text">found to be statistically acceptable by Dr Lyle Broemling</text>
<text top="532" left="315" width="241" height="9" font="font5" id="p1_t91" reading_order_no="90" segment_no="8" tag_type="text">(Associated Professor of Biostatistics, The University of</text>
<text top="543" left="315" width="153" height="9" font="font5" id="p1_t92" reading_order_no="91" segment_no="8" tag_type="text">Texas MD Anderson Cancer Center).</text>
<text top="567" left="315" width="39" height="10" font="font10" id="p1_t93" reading_order_no="92" segment_no="9" tag_type="title">Results</text>
<text top="579" left="315" width="227" height="8" font="font7" id="p1_t94" reading_order_no="93" segment_no="11" tag_type="title">Induction of antigen-specific IgG by vaccination with</text>
<text top="590" left="315" width="38" height="8" font="font7" id="p1_t95" reading_order_no="94" segment_no="11" tag_type="title">VRP-neu</text>
<text top="602" left="315" width="241" height="9" font="font5" id="p1_t96" reading_order_no="95" segment_no="12" tag_type="text">Groups of Balb/c mice ( n = 5 per group) were vaccinated</text>
<text top="614" left="315" width="240" height="9" font="font5" id="p1_t97" reading_order_no="96" segment_no="12" tag_type="text">once subcutaneously in one hind leg footpad with either</text>
<text top="625" left="315" width="241" height="10" font="font5" id="p1_t98" reading_order_no="97" segment_no="12" tag_type="text">10 6 IU VRP- neu or 10 6 IU VRP-HA suspended in PBS. The</text>
<text top="637" left="315" width="240" height="9" font="font5" id="p1_t99" reading_order_no="98" segment_no="12" tag_type="text">HER2/ neu -specific humoral response of serum pooled</text>
<text top="649" left="315" width="240" height="9" font="font5" id="p1_t100" reading_order_no="99" segment_no="12" tag_type="text">from mice in each group was measured 14 days later by<i>neu</i></text>
<text top="661" left="315" width="240" height="9" font="font5" id="p1_t101" reading_order_no="100" segment_no="12" tag_type="text">flow cytometry using A2L2 cells. Compared with the mice</text>
<text top="673" left="315" width="241" height="9" font="font5" id="p1_t102" reading_order_no="101" segment_no="12" tag_type="text">vaccinated with VRP-HA, the mice vaccinated with VRP-</text>
<text top="684" left="315" width="240" height="9" font="font9" id="p1_t103" reading_order_no="102" segment_no="12" tag_type="text">neu had a strong IgG response (Fig. 1). Pre-immune sera</text>
<text top="696" left="315" width="241" height="9" font="font5" id="p1_t104" reading_order_no="103" segment_no="12" tag_type="text">for both groups were nonreactive with A2L2 cells, and</text>
<text top="708" left="315" width="240" height="9" font="font5" id="p1_t105" reading_order_no="104" segment_no="12" tag_type="text">immune sera from both vaccinated groups were nonreac-</text>
</page>
</pdf2xml>
